Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation (Q35231255)

7 August 2017

Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation (English)

1 reference

7 August 2017

0 references

1 reference

Lucy D Burr

5

0 references

Sumaira Z Hasnain

object named as

Sumaira Z Hasnain

6

0 references

Geraint B Rogers

object named as

Geraint B Rogers

4

0 references

Michael A McGuckin

object named as

Michael A McGuckin

8

0 references

author name string

Alice C-H Chen

1

1 reference

7 August 2017

Megan L Martin

2

1 reference

7 August 2017

Rohan Lourie

3

1 reference

7 August 2017

Simon D Bowler

7

1 reference

7 August 2017

David J Serisier

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

30 March 2015

1 reference

7 August 2017

1 reference

7 August 2017

10

1 reference

7 August 2017

e0119325

1 reference

7 August 2017

3

1 reference

Creative Commons Attribution 4.0 International

7 August 2017

start time

30 March 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

A novel microbiota stratification system predicts future exacerbations in bronchiectasis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

The Th17 pathway in cystic fibrosis lung disease.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Innate IL-17-producing cells: the sentinels of the immune system

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Interleukin-17 and type 17 helper T cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Clinical challenges in managing bronchiectasis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Regulation of inflammatory responses by IL-17F

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Inflammation: a two-edged sword--the model of bronchiectasis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4379018

Interleukin-17 and cystic fibrosis lung disease

26 September 2018

1 reference

12 December 2020

Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition

1 reference

12 December 2020

Macrophages, neutrophils and tumour necrosis factor-alpha expression in bronchiectatic airways in vivo

1 reference

12 December 2020

Bronchial inflammation and colonization in patients with clinically stable bronchiectasis

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0119325

Identifiers

DOI

1 reference

release_nn3by4zaq5dc3bs56a2aco3p3e

7 August 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nn3by4zaq5dc3bs56a2aco3p3e

24 November 2022

mapped directly with Wikidata item

PMCID

4379018

1 reference

7 August 2017

1 reference